[HTML][HTML] Battle of the milky way: Lymphatic targeted drug delivery for pathogen eradication

A Taheri, KE Bremmell, P Joyce… - Journal of Controlled …, 2023 - Elsevier
Many viruses, bacteria, and parasites rely on the lymphatic system for survival, replication,
and dissemination. While conventional anti-infectives can combat infection-causing agents …

[HTML][HTML] New insights into transcription elongation control of HIV-1 latency and rebound

U Mbonye, F Kizito, J Karn - Trends in Immunology, 2023 - cell.com
Antiretroviral therapy reduces circulating HIV-1 to undetectable amounts but does not
eliminate the virus due to the persistence of a stable reservoir of latently infected cells. The …

A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection

A Wahl, W Yao, B Liao, M Chateau, C Richardson… - Nature …, 2024 - nature.com
Abstract Germ-free (GF) mice, which are depleted of their resident microbiota, are the gold
standard for exploring the role of the microbiome in health and disease; however, they are of …

[HTML][HTML] Initial productive and latent HIV infections originate in vivo by infection of resting T cells

SW Wietgrefe, J Anderson, L Duan… - The Journal of …, 2023 - Am Soc Clin Investig
Productively infected cells are generally thought to arise from HIV infection of activated
CD4+ T cells, and these infected activated cells are thought to be a recurring source of …

[HTML][HTML] Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive …

MTA Abbate, IK Ramöller, AH Sabri, AJ Paredes… - International Journal of …, 2023 - Elsevier
HIV/AIDS remains a major global public health issue. While antiretroviral therapy is effective
at reducing the viral load in the blood, up to 50% of those with HIV suffer from some degree …

Lymphoid tissues contribute to plasma viral clonotypes early after antiretroviral therapy interruption in SIV-infected rhesus macaques

A Solis-Leal, N Boby, S Mallick, Y Cheng… - Science Translational …, 2023 - science.org
The rebound-competent viral reservoir, composed of a virus that is able to persist during
antiretroviral therapy (ART) and mediate reactivation of systemic viral replication and …

A Phenotypic screen identifies potent Dpp9 inhibitors capable of killing HIV-1 infected cells

KP Moore, AG Schwaid, M Tudor, S Park… - ACS Chemical …, 2022 - ACS Publications
Although current antiretroviral therapy can control HIV-1 replication and prevent disease
progression, it is not curative. Identifying mechanisms that can lead to eradication of …

[HTML][HTML] Mucosal T-cell responses to chronic viral infections: Implications for vaccine design

M Al-Talib, S Dimonte, IR Humphreys - Cellular & Molecular …, 2024 - nature.com
Mucosal surfaces that line the respiratory, gastrointestinal and genitourinary tracts are the
major interfaces between the immune system and the environment. Their unique …

Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions

MJ Peluso, J Donatelli, TJ Henrich - Translational Research, 2022 - Elsevier
The current era of COVID-19 is characterized by emerging variants of concern, waning
vaccine-and natural infection-induced immunity, debate over the timing and necessity of …

[HTML][HTML] Identification of aryl hydrocarbon receptor as a barrier to HIV-1 infection and outgrowth in CD4+ T cells

D Chatterjee, Y Zhang, CD Ngassaki-Yoka, A Dutilleul… - Cell reports, 2023 - cell.com
The aryl hydrocarbon receptor (AhR) regulates Th17-polarized CD4+ T cell functions, but its
role in HIV-1 replication/outgrowth remains unknown. Genetic (CRISPR-Cas9) and …